Pregabalin Capsule
Product Images NDC 80425-0421

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 80425-0421). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Equation (Equation)

Equation (Equation)
The text appears to be a mathematical formula for calculating creatinine clearance (CLCr) based on age, weight, and serum creatinine level for female patients. It mentions the value of CLCr should be greater than 0.85 and uses the abbreviation "rag/dL" for serum creatinine measurement.*
FDA Label Image

Fig 1 (Fig 1)

Fig 1 (Fig 1)
FDA Label Image

Fig 10 (Fig 10)

Fig 10 (Fig 10)
FDA Label Image

Fig 11 (Fig 11)

Fig 11 (Fig 11)
FDA Label Image

Fig 12 (Fig 12)

Fig 12 (Fig 12)
FDA Label Image

Fig 2 (Fig 2)

Fig 2 (Fig 2)
FDA Label Image

Fig 3 (Fig 3)

Fig 3 (Fig 3)
FDA Label Image

Fig 4 (Fig 4)

Fig 4 (Fig 4)
Percentage Improvement in Pain from Baseline: There is a report of patients whose pain has improved. Dosages of Pregabalin 200 mg three times a day and Pregabalin 100 mg three times a day were administered, along with a placebo. The rest of the text is not readable.*
FDA Label Image

Fig 5 (Fig 5)

Fig 5 (Fig 5)
FDA Label Image

Fig 6 (Fig 6)

Fig 6 (Fig 6)
This is data obtained from Study E1 and E3, which compares the effectiveness of placebo and different doses of a medication. The results show the percentage of improvement in the condition being treated for each dose compared to placebo. The highest dose (600mg/day) was statistically significant in improving the condition compared to placebo.*
FDA Label Image

Fig 7 (Fig 7)

Fig 7 (Fig 7)
FDA Label Image

Fig 9 (Fig 9)

Fig 9 (Fig 9)
This is a chart showing the percent improvement in pain from baseline for different doses of Pregabalin and Fiacsto. There are percentages ranging from 0% - 100% for each medication.*
FDA Label Image

Pregabalin #90 (Pregabalin 150mg Cap Qty 90 80425 0185)

Pregabalin #90 (Pregabalin 150mg Cap Qty 90 80425 0185)
FDA Label Image

Structure (Structure)

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.